Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-022653
Filing Date
2025-02-18
Accepted
2025-02-18 19:30:46
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3327
  Complete submission text file 0000950170-25-022653.txt   4742
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235
Business Address
Hopkins Janet Jill (Reporting) CIK: 0001997710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 25636792